Pulmonary embolism, or PE, is a deadly condition causing blood clots within a patient’s lungs that has grown in prevalence during the COVID-19 pandemic. The Indigo Aspiration System with Lightning 12 ...

Results of EXTRACT-PE Trial presented at Vascular InterVentional Advances (VIVA) Annual Meeting “The Indigo Aspiration System has demonstrated tremendous potential to address patients with clot in ...

Please provide your email address to receive an email when new articles are posted on . Penumbra announced its aspiration system to treat pulmonary embolism has received clearance for an expanded ...

Please provide your email address to receive an email when new articles are posted on . The new system (Indigo System Lightning 12) combines an aspiration catheter with an intelligent aspiration ...

Alexandria, Va., USA -- High-volume aspirators are recommended in dental clinics during the COVID-19 pandemic, but the study "SARS-CoV-2 Seropositivity Among Dental Staff and the Role of Aspirating ...

Penumbra's AI-guided aspiration system and scalable platform uniquely position it as a leader in stroke and PE intervention, justifying a Buy rating. First-mover advantage in intelligent thrombectomy, ...

PARK CITY, Utah. -- Dr. Nick Cavros, interventional cardiologist with Cardiovascular Institute of the South (CIS) at Lafayette General Medical Center in Lafayette, Louisiana, used a new hand-held ...

The type of high-volume aspirating system being used at a dental practice can significantly affect the incidence of SARS-CoV-2 infection among staff who work there, according to a study published on ...

PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc., a company singularly dedicated to answering unsolved problems in stroke, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for ...